plx-200
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Sep 1, 2021 (NCT04637282)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Alpha-tocopherol transfer proteinACTIVATOR
TTPA activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04637282 | Phase 3 | Sep 1, 2021 | Polaryx Therapeutics, Polaryx Therapeutics, Inc. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Polaryx Therapeutics | For profit | 1 | 0 | 1 | 2021 |
| Polaryx Therapeutics, Inc. | For profit | 1 | 1 | 1 | 2021 |
2 organizations
Page 1 / 1